Detalles de la búsqueda
1.
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
Gynecol Oncol
; 183: 25-32, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490057
2.
Correlation of RANK and RANKL with mammographic density in primary breast cancer patients.
Arch Gynecol Obstet
; 2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38836929
3.
Return of individual genomic research results within the PRAEGNANT multicenter registry study.
Breast Cancer Res Treat
; 197(2): 355-368, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36409394
4.
Learning laparoscopic hysterectomy: analysis of different surgeons' individual learning curves.
Arch Gynecol Obstet
; 307(4): 1065-1072, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36580116
5.
Genetic variants in the genes of the sex steroid hormone metabolism and depressive symptoms during and after pregnancy.
Arch Gynecol Obstet
; 307(6): 1763-1770, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35680688
6.
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
Br J Cancer
; 126(12): 1715-1724, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35194193
7.
Genetic variants in the glucocorticoid pathway genes and birth weight.
Arch Gynecol Obstet
; 303(2): 427-434, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32886236
8.
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial.
Breast Cancer Res
; 22(1): 111, 2020 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33097092
9.
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.
Breast Cancer Res Treat
; 184(2): 311-324, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852708
10.
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany.
BMC Cancer
; 20(1): 1091, 2020 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33176725
11.
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center.
Arch Gynecol Obstet
; 301(5): 1299-1306, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32274639
12.
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients.
Int J Cancer
; 145(8): 2114-2121, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30901076
13.
Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer.
Breast Cancer Res Treat
; 175(3): 617-625, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30868391
14.
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis.
Breast Cancer Res Treat
; 173(2): 319-328, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30324275
15.
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
Breast Cancer Res Treat
; 174(2): 453-461, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30603996
16.
The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer.
Breast Cancer Res Treat
; 171(3): 747-758, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29951969
17.
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.
Breast Cancer Res Treat
; 171(1): 85-94, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29725888
18.
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer.
BMC Cancer
; 18(1): 1051, 2018 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30373556
19.
Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
BMC Cancer
; 18(1): 204, 2018 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29463222
20.
Predicting attention deficit hyperactivity disorder using pregnancy and birth characteristics.
Arch Gynecol Obstet
; 298(5): 889-895, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30196359